Checking procalcitonin suitability for prognosis and antimicrobial therapy monitoring in burn patients

Burns & Trauma

Table 8 Evolution of procalcitonin levels in the first week of antimicrobial therapy for survivor and non-survivor groups

First week of antimicrobial therapy
Day	Survivors			Non-survivors
Day	N	Median	Q1–Q3	N	Median	Q1–Q3
1	66	0.6300	0.240–3.020	24	2.080	0.945–2.810
2	68	0.5500	0.225–2.475	24	2.680	0.870–5.155
3	66	0.4950	0.220–1.300	24	1.945	0.750–7.205
4	66	0.4400	0.220–1.140	23	2.010	0.940–4.485
5	65	0.3500	0.170–1.140	22	1.065	0.550–4.490
6	61	0.3700	0.170–1.250	21	1.070	0.380–3.270
7	59	0.3700	0.175–0.920	21	0.960	0.660–2.420

ISSN: 2321-3876